Dynamic Technology Lab Private Ltd bought a new stake in Analogic Corp. (NASDAQ:ALOG) during the second quarter, according to its most recent Form 13F filing with the SEC. The firm bought 3,276 shares of the company’s stock, valued at approximately $260,000.
A number of other hedge funds also recently bought and sold shares of ALOG. Legal & General Group Plc raised its stake in shares of Analogic Corp. by 24.5% in the first quarter. Legal & General Group Plc now owns 3,284 shares of the company’s stock valued at $259,000 after buying an additional 646 shares during the last quarter. GSA Capital Partners LLP purchased a new stake in shares of Analogic Corp. during the second quarter worth about $283,000. Princeton Alpha Management LP purchased a new stake in shares of Analogic Corp. during the second quarter worth about $303,000. BNP Paribas Arbitrage SA raised its stake in shares of Analogic Corp. by 104.7% in the second quarter. BNP Paribas Arbitrage SA now owns 4,009 shares of the company’s stock worth $318,000 after buying an additional 2,051 shares in the last quarter. Finally, Capstone Asset Management Co. raised its stake in shares of Analogic Corp. by 9.9% in the second quarter. Capstone Asset Management Co. now owns 4,336 shares of the company’s stock worth $344,000 after buying an additional 390 shares in the last quarter. 99.81% of the stock is currently owned by hedge funds and other institutional investors.
Analogic Corp. (NASDAQ:ALOG) opened at 88.60 on Friday. Analogic Corp. has a 12 month low of $68.71 and a 12 month high of $94.39. The stock has a market cap of $1.10 billion, a P/E ratio of 92.29 and a beta of 0.95. The company’s 50-day moving average price is $89.54 and its 200-day moving average price is $83.08.
Analogic Corp. (NASDAQ:ALOG) last released its quarterly earnings results on Wednesday, September 21st. The company reported $1.02 earnings per share for the quarter, missing analysts’ consensus estimates of $1.17 by $0.15. The firm earned $138.10 million during the quarter, compared to analyst estimates of $139.03 million. Analogic Corp. had a return on equity of 7.33% and a net margin of 2.38%. The business’s revenue was down 10.6% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.28 EPS. Equities analysts forecast that Analogic Corp. will post $4.04 earnings per share for the current year.
The business also recently announced a quarterly dividend, which will be paid on Wednesday, October 12th. Shareholders of record on Thursday, September 1st will be issued a dividend of $0.10 per share. This represents a $0.40 dividend on an annualized basis and a yield of 0.45%. The ex-dividend date of this dividend is Wednesday, September 28th. Analogic Corp.’s dividend payout ratio (DPR) is presently 41.24%.
ALOG has been the topic of a number of research analyst reports. TheStreet raised Analogic Corp. from a “hold” rating to a “buy” rating in a research note on Wednesday, June 8th. Zacks Investment Research lowered Analogic Corp. from a “hold” rating to a “sell” rating in a research note on Tuesday, September 27th. Finally, Brean Capital reaffirmed a “buy” rating and issued a $100.00 price target (up from $90.00) on shares of Analogic Corp. in a research note on Thursday, September 22nd.
In other news, CEO James W. Green sold 500 shares of the firm’s stock in a transaction on Thursday, September 22nd. The stock was sold at an average price of $91.25, for a total transaction of $45,625.00. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, insider Mervat Faltas sold 1,897 shares of the firm’s stock in a transaction on Thursday, July 14th. The stock was sold at an average price of $83.00, for a total value of $157,451.00. Following the sale, the insider now owns 7,765 shares in the company, valued at approximately $644,495. The disclosure for this sale can be found here. Company insiders own 2.40% of the company’s stock.
Analogic Corp. Company Profile
Analogic Corporation designs, manufactures and commercializes guidance, diagnostic imaging and threat detection technologies to advance the practice of medicine and save lives. The Company operates through three business segments: Medical Imaging, Ultrasound, and Security and Detection. The Company’s Medical Imaging segment provides medical imaging systems and subsystems for computed tomography (CT), magnetic resonance imaging (MRI) and high-resolution digital mammography.
Want to see what other hedge funds are holding ALOG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Analogic Corp. (NASDAQ:ALOG).
Receive News & Ratings for Analogic Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Analogic Corp. and related companies with MarketBeat.com's FREE daily email newsletter.